BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3859218)

  • 1. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin.
    Calandra GB; Brown KR; Grad LC; Ahonkhai VI; Wang C; Aziz MA
    Am J Med; 1985 Jun; 78(6A):73-8. PubMed ID: 3859218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients.
    Calandra GB; Wang C; Aziz M; Brown KR
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():193-202. PubMed ID: 3469194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with imipenem/cilastatin: analysis of a multicenter study.
    Shah PM
    Rev Infect Dis; 1985; 7 Suppl 3():S471-5. PubMed ID: 3901210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
    Calandra G; Lydick E; Carrigan J; Weiss L; Guess H
    Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on imipenem/cilastatin sodium in pediatric field].
    Nagata K; Yokoyama M; Ohnishi A; Izumi Y
    Jpn J Antibiot; 1986 Jul; 39(7):1708-14. PubMed ID: 3464774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of imipenem/cilastatin in treatment of complicated urinary tract infections.
    Cox CE; Corrado ML
    Am J Med; 1985 Jun; 78(6A):92-4. PubMed ID: 3859220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin in the treatment of osteomyelitis.
    MacGregor RR; Gentry LO
    Am J Med; 1985 Jun; 78(6A):100-3. PubMed ID: 3859207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin: general experience in a community hospital.
    Iannini PB; Kunkel MJ; Hilton E; Iannini GM
    Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem/cilastatin in the treatment of serious bacterial infections.
    Chiodini PL; Geddes AM; Smith EG; Conlon CP; Farrell ID
    Rev Infect Dis; 1985; 7 Suppl 3():S490-5. PubMed ID: 3901212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
    Solomkin JS; Fant WK; Rivera JO; Alexander JW
    Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of imipenem/cilastatin on the colonic microflora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.